![]() |
Volumn 8, Issue 3, 2001, Pages 191-195
|
Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE;
AROMATASE INHIBITOR;
ESTROGEN RECEPTOR;
FADROZOLE;
LETROZOLE;
MEGESTROL ACETATE;
ONCOPROTEIN;
TAMOXIFEN;
TAMOXIFEN CITRATE;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER INHIBITION;
CANCER RESISTANCE;
CANCER SURVIVAL;
CELL ONCOGENE;
CELL PROLIFERATION;
CELL STRAIN MCF 7;
CLINICAL TRIAL;
CONFERENCE PAPER;
GENE FUNCTION;
GENE OVEREXPRESSION;
GENETIC TRANSFECTION;
HORMONE DEPENDENCE;
HUMAN;
ONCOGENE NEU;
PROTEIN EXPRESSION;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
RECEPTOR, ERBB-2;
|
EID: 0034794636
PISSN: 13510088
EISSN: None
Source Type: Journal
DOI: 10.1677/erc.0.0080191 Document Type: Conference Paper |
Times cited : (147)
|
References (16)
|